Symbols

Symbols

QNTM

Quantum BioPharma·NASDAQ

--

--(--)

--

--(--)

QNTM fundamentals

QNTM Q4 2025 Earnings Preview

Quantum BioPharma (QNTM) expects to report earnings on Mar 24, 2026, with estimated revenue of 0 (YoY --), and EPS at -1.0215 (YoY +63.23%).

Revenue estimate / YoY

0

--

EPS estimate / YoY

-1.0215

+63.23%

Report date

Mar 24, 2026

EPS

Actual		27.5342	-68.7361		-22.8815	-9.5744						-9.3119	-1.9506	-2.6784	-3.2666	-0.0788	-2.8767	-2.7783	-3.4235	-3.2651	-1.2632
Forecast			-40.1767										-9.086	-9.3131	-3.2757	-3.8909	-2.7686	-0.7784	-0.6248	-0.1697	-2.6589	-1.0215
Surprise	0.00%	0.00%	-71.08%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+78.53%	+71.24%	+0.28%	+97.97%	-3.90%	-256.92%	-447.94%	-1824.04%	+52.49%	0.00%

Revenue

Actual	--	6.14B	0	--	--	--	--	--	--	--	--	0	--	--	--	0	0	0	2.09M	0	0	--
Forecast	--	--	0	--	--	--	--	--	--	--	--	--	0	0	0	0	0	924.32K	2.09M	2.89M	889.59K	0
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-100.00%	+0.12%	-100.00%	-100.00%	0.00%

Earnings Call

You can ask Aime

What were the key takeaways from Quantum BioPharma's earnings call?

What does Quantum BioPharma do and what are its main business segments?

What is Quantum BioPharma's gross profit margin?

What were the key takeaways from Quantum BioPharma’s earnings call?

What factors drove the changes in Quantum BioPharma's revenue and profit?

What guidance did Quantum BioPharma's management provide for the next earnings period?

What is Quantum BioPharma's latest dividend and current dividend yield?

Did Quantum BioPharma beat or miss consensus estimates last quarter?